Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 961 of 5804
-
Can pharmacy training boost HPV shots and prevent future cancers?
Prevention Not yet recruitingThis clinical trial compares usual care to interpersonal communication training and vaccination workflow training, alone or in combination, for improving communication about and recommendations for human papillomavirus (HPV) and other vaccinations in pharmacies. Low HPV vaccinati…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Jul 24, 2026 00:00 UTC
-
Could a probiotic fight anal cancer in HIV patients?
Disease control Not yet recruitingThis study is focused on treatment of anal high-grade squamous intraepithelial lesions (HSIL) in persons with HIV (PWH), with the ultimate goal of applying the approach toward prevention of anal cancer in this population
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New combo therapy aims to prevent lung damage in tiniest preemies
Disease control Not yet recruitingThis clinical trial is being done to evaluate the safety and clinical response of late surfactant treatment with budesonide in extremely preterm infants requiring mechanical ventilation at 7-14 days of age.
Phase: PHASE1, PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a common heart drug treat kaposi sarcoma?
Disease control Not yet recruitingA clinical study of propranolol for the treatment of Kaposi Sarcoma in children and adults. This study will be an open-label single armed treatment trial that will test the effectiveness and the safety of treating Kaposi Sarcoma with propranolol.
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Experimental combo aims to reignite immune attack on lung cancer
Disease control Not yet recruitingThis phase II trial tests how well SX-682 and atezolizumab works for the treatment of non-small cell lung cancer (NSCLC) that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has spread from where it first …
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Simple Pre-Surgery trick may shield kidneys from damage
Disease control Not yet recruitingJuxta-renal abdominal aortic aneurysms (AAA) are challenging to treat with standard endovascular techniques (EVAR) due to their proximity to the renal arteries. Open surgical repair continues to be used in patients unsuitable for EVAR but carries a high risk of acute kidney injur…
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Ear zap might tame racing heart in POTS
Symptom relief Not yet recruitingAutonomic nervous system imbalance causes postural tachycardia and related cardiac symptoms in Postural Orthostatic Tachycardia Syndrome (POTS). The impact of POTS is more far-reaching than postural tachycardia. Several systemic, autonomic symptoms along with neuro-cognitive dysf…
Phase: NA • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Brain stent trial aims to ease pressure headaches and save sight
Disease control Not yet recruitingThe objective of this clinical investigation is to evaluate and demonstrate the clinical benefit, performance, and safety of the SILANCE Stent, which is specifically designed for the treatment of patients with symptomatic sinus stenoses associated with IIH.
Phase: NA • Sponsor: Acandis GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New hope for prostate cancer: drug combo aims to delay tumor growth
Disease control Not yet recruitingThis is a multi-center single arm phase II study of zanzalintinib after Pluvicto in chemotherapy-naïve mCRPC. Subjects will receive zanzalintinib 60mg orally (PO) once daily. Zanzalintinib may continue until evidence of radiographic progression, intolerable adverse events, or wit…
Phase: PHASE2 • Sponsor: Stuthi Perimbeti • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Zapping prostate tumors with extra precision: new trial aims for fewer side effects
Disease control Not yet recruitingThe goal of this clinical trial is to determine the safety of stereotactic body radiation therapy (SBRT) microboost technique in patients with low to intermediate risk prostate cancer. The main question it aims to answer is: Is microboost SBRT with whole gland de-escalation both …
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New daily pill could help teens manage type 2 diabetes
Disease control Not yet recruitingThis study looks at how well a medicine called orforglipron works compared to another medicine called dulaglutide in pediatric participants aged 10 to less than 18 years with type 2 diabetes. The study will also check how safe these medicines are and how the body processes them. …
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden sarcoma tumors in Children's lungs
Disease control Not yet recruitingSubjects will undergo infusion of 5 mg/kg indocyanine green, ICG ("TumorGlow") intravenously up to 5-days prior to surgery. Then, during the surgical procedure the next day, the subjects will undergo standard-of-care surgery. During the surgery, the fluorescence from the tumor wi…
Phase: EARLY_PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a radiofrequency device help fight advanced breast cancer?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if adding the TheraBionic P1 device to standard of care third line treatment for adult women with metastatic triple negative breast cancer (mTNBC) who have failed, not tolerated, or progressed on standard first- and second-line treatmen…
Phase: NA • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Real-World study tests migraine prevention pill in UK clinics
Disease control Not yet recruitingMigraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. The study will assess the effectiveness of atogepant for the preventive treatment of migraine in adult patients in the UK. At…
Sponsor: AbbVie • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Smartwatch data could decide when to fix a leaky heart valve
Knowledge-focused Not yet recruitingRemote-AS aims to develop a remote digital monitoring cohort of people with AS and use these data to establish a digital twin intervention to personalise risks and benefits, and optimise the time of surgical or transcatheter aortic valve replacement (AVR) referral. Our digital so…
Sponsor: Baker Heart and Diabetes Institute • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Virtual reality cartoons could replace needles for Kids' dental fear
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if virtual reality distraction can reduce dental anxiety and pain perception in children aged 6-10 years undergoing simple dental extraction. The main questions it aims to answer are: Does virtual reality distraction lower dental anxie…
Phase: NA • Sponsor: Sultan Qaboos University • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Acupuncture may offer Drug-Free relief for breast cancer Survivors' lingering symptoms
Symptom relief Not yet recruitingThe purpose of this study is to examine the effect, mediators and predictors of treatment response of acupuncture in treating the psychoneurological symptom cluster (pain, fatigue, sleep disturbance) among breast cancer survivors.
Phase: PHASE3 • Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
A personal guide to better heart health after pregnancy complications
Disease control Not yet recruitingThis study will examine whether a patient navigation program can help improve long-term heart health among people who experienced high blood pressure disorders during pregnancy at Boston Medical Center (BMC). Conditions such as preeclampsia and other hypertensive disorders of pre…
Phase: NA • Sponsor: Boston Medical Center • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Custom 3D-Printed stents could spare kids with brain cancer from painful mouth sores
Symptom relief Not yet recruitingBrain cancer patients undergoing radiotherapy may experience oral complications such as oral mucositis, gingival inflammation, plaque accumulation, radiation-induced caries, and reduced oral-health-related quality of life due to scatter radiation affecting oral tissues. Although…
Phase: NA • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
Could the speed of blood sugar drop harm the eyes? a study puts it to the test.
Knowledge-focused Not yet recruitingThe GLIDE study looks at how the small blood vessels of the eye respond during the first months of a new diabetes medicine. Two widely used classes of glucose-lowering drugs, GLP-1 receptor agonists and SGLT2 inhibitors, are compared in adults with type 2 diabetes who have no dia…
Sponsor: Thammasart University Hospital • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC